跳至主要内容
临床试验/EUCTR2020-002144-23-ES
EUCTR2020-002144-23-ES进行中(未招募)1 期

Randomized, double-blind clinical trial to assess the efficacy of tranexamic acid in reducing blood loss in patients with hip fracture

Asociación Instituto Biodonostia0 个研究点目标入组 644 人开始时间: 2021年11月16日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
644

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Who is over 65 years of age, of both sexes.
  • - Accept participation in the study (informed consent that will be signed by the patient or family member / legal representative depending on the degree of autonomy of the patient).
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 644

排除标准

  • - In treatment with another experimental drug (not participating in another clinical trial with an experimental drug).
  • - The refusal of the patient to participate in the study.
  • - Known allergy to TXA.
  • - Patients with a history of seizures.
  • - Patients with severe kidney and liver failure.

研究者

发起方
Asociación Instituto Biodonostia

相似试验